Login
Agenda
9 - 12 March 2010
ISICEM International Symposium on Intensive Care and Emergency Medicine - Brussels (Belgium)
9 -11 June 2010
EACTA European Association of Cardiothoracic Anaesthesiologists - Edinburgh (UK)
12-15 June 2010
ESA European Society of Anaesthesiology - Helsinki (Finland)
18-22 September 2010
ERS European Respiratory Society - Barcellona (Spain)
9 -13 October 2010
ESICM European Society of Intensive Care Medicine - Barcellona (Spain)
> International events
|
|
|
| Monday, 28 April 2008 | |
|
Jackson SR, Ernst NE, Mueller EW, Butler KL., Department of Surgery, University of Cincinnati, OH, USA, Am J Surg. 2008 Feb;195(2):159-63
BACKGROUND: Bronchoalveolar lavage (BAL) is recommended to facilitate the diagnosis of ventilator-associated pneumonia (VAP). It is unclear if bilateral sampling improves the accuracy of BAL.
METHODS: Consecutive patients with clinical suspicion for VAP were analyzed. All patients underwent bilateral BAL. A threshold of >10(4) colony-forming units (cfu)/mL was diagnostic for VAP (VAP positive). Samples were concordant if the organism(s) and thresholds from both lungs were diagnostically consistent. Organisms </=10(4) cfu/mL with growth on the contralateral sample >10(4) cfu/mL were considered false-negative samples.
RESULTS: Between November 2005 and April 2006, 73 patients were considered clinically suspicious for VAP. Forty-four (60%) patients were VAP positive. Twenty-eight (64%) VAP patients had concordant samples. Overall, there were 15 false-negative samples. Sole use of the unilateral samples to guide treatment would have inappropriately directed antibiotic avoidance and/or discontinuation in 25% of VAP patients. Influence of the chest radiograph was equivocal because of the presence of bilateral infiltrates in 80% of discordant samples.
CONCLUSIONS: Bilateral BAL improves the accuracy of bronchoscopy in diagnosing VAP. Unilateral BAL may be insensitive in patients with clinically significant contralateral infection. |
|
| Last Updated ( Monday, 28 April 2008 ) |
| < Prev | Next > |
|---|
![]() |
| Select and watch from the following webinars |












